Berkshire a Net Seller of Equities in Fourth Quarter
The wide-moat firm added to its stake in Occidental Petroleum while whittling its stake in Wells Fargo.
There were few surprises in wide-moat Berkshire Hathaway's (BRK.A)/(BRK.B) fourth-quarter 13-F filing, with the company adding to its stake in Occidental Petroleum (purchasing another 11.5 million shares for an estimated $490 million, well below the exercise price of $62.50 per share attached to the warrants Berkshire received to purchase up to 80 million shares of Occidental's common stock as part of its deal to help finance the oil company's purchase of Anadarko) while also continuing to whittle down its stake in Wells Fargo (selling off close to 15% of its holdings in the bank as part of ongoing moves to keep the insurer’s stake below the 10% bank holding company threshold that would invite increased regulatory oversight).
As for the other purchases during the quarter, Berkshire picked up another 0.5 million shares of Restoration Hardware for an estimated $100 million, another 2.7 million shares of General Motors for an estimated $100 million, and another 4.3 million shares of Suncor Energy for an estimated $135 million. The insurer also made two new-money purchases during the period, picking up 0.6 million shares of Biogen for an estimated $170 million and 18.9 million shares of Kroger for an estimated $520 million.
As for the other sales made during the period, Berkshire once again trimmed its stake in Apple (selling 3.7 million shares for an estimated $950 million), sold off close to 35% of its stake in Goldman Sachs (selling 6.3 million shares for an estimated $1.4 billion), and made small adjustments to its holdings in American Airlines, Bank of New York Mellon, and Bank of America. The insurer also came close to clearing out its small positions in Phillips 66 and The Travelers Companies, both of which we would be surprised to see still in the portfolio at the end of the first quarter. Net proceeds from the company's purchases and sales amounted to an estimated $5.2 billion, so we would expect that Berkshire's cash on hand exceeded $135 billion at the end of last year.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Greggory Warren does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.